XIAOMI-W
01810
BABA-W
09988
MIXUE GROUP
02097
4
TENCENT
00700
5
NIO-SW
09866
HK Stock MarketDetailed Quotes
03320 CHINARES PHARMA
- 5.290
- +0.050+0.95%
Not Open Mar 11 16:08 CST
33.23BMarket Cap8.03P/E (TTM)
5.310High5.160Low6.43MVolume5.180Open5.240Pre Close33.60MTurnover0.10%Turnover Ratio7.81P/E (Static)6.28BShares7.11052wk High0.63P/B33.23BFloat Cap4.36052wk Low0.26Dividend TTM6.28BShs Float12.230Historical High0.170Dividend LFY2.86%Amplitude2.610Historical Low5.221Avg Price500Lot Size4.93%Div YieldTTM3.21%Div Yield LFY
CHINARES PHARMA Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4.71%128.6B | 12.16%244.7B | -2.31%122.82B | -7.86%218.18B | 9.81%125.72B | 18.15%236.81B | 28.08%114.49B | -1.97%200.42B | -12.30%89.39B | 7.78%204.45B |
| Operating income | 4.71%128.6B | 12.16%244.7B | -2.31%122.82B | -7.86%218.18B | 9.81%125.72B | 18.15%236.81B | 28.08%114.49B | -1.97%200.42B | -12.30%89.39B | 7.78%204.45B |
| Cost of sales | -4.47%-107.66B | -11.81%-206.37B | 2.67%-103.06B | 8.37%-184.56B | -9.13%-105.88B | -19.80%-201.43B | -30.20%-97.02B | 1.35%-168.13B | 11.80%-74.52B | -10.13%-170.44B |
| Operating expenses | -4.47%-107.66B | -11.81%-206.37B | 2.67%-103.06B | 8.37%-184.56B | -9.13%-105.88B | -19.80%-201.43B | -30.20%-97.02B | 1.35%-168.13B | 11.80%-74.52B | -10.13%-170.44B |
| Gross profit | 5.94%20.93B | 14.04%38.34B | -0.36%19.76B | -4.98%33.62B | 13.55%19.83B | 9.56%35.38B | 17.48%17.47B | -5.07%32.29B | -14.72%14.87B | -2.61%34.02B |
| Selling expenses | -1.49%-9.38B | -15.34%-18.91B | -1.80%-9.24B | 6.48%-16.4B | -9.59%-9.08B | -9.37%-17.53B | -22.35%-8.28B | 16.46%-16.03B | 24.06%-6.77B | -4.62%-19.19B |
| Administrative expenses | -7.00%-3.04B | -13.44%-6.33B | 2.98%-2.85B | 10.55%-5.58B | -8.58%-2.93B | -12.07%-6.24B | -25.74%-2.7B | -6.93%-5.56B | 8.28%-2.15B | -8.56%-5.2B |
| Operating interest expense | ---- | ---- | ---- | ---- | 7.39%-1.36B | 12.96%-2.74B | 5.32%-1.47B | 15.06%-3.15B | ---1.55B | ---3.71B |
| Special items of operating profit | -110.78%-857.54M | 2.47%-1.84B | -542.26%-406.85M | -143.49%-1.88B | -540.76%-63.35M | -14.13%-773.81M | -28.30%14.37M | -215.67%-677.99M | -97.90%20.05M | 15.80%586.15M |
| Operating profit | 5.31%7.65B | 15.37%11.26B | 13.64%7.27B | 20.58%9.76B | 27.31%6.4B | 17.85%8.09B | 13.80%5.02B | 5.69%6.87B | -38.10%4.41B | -47.17%6.5B |
| Financing income | 59.52%372.15M | -18.51%587.69M | --233.3M | --721.18M | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cost | 17.60%-1.18B | 2.74%-2.39B | ---1.43B | ---2.45B | ---- | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | -6.25%198.77M | 25.51%417.11M | 14.04%212.01M | 5.98%332.34M | 30.26%185.91M | 51.60%313.6M | 89.37%142.73M | 47.31%206.85M | 11.51%75.37M | 2.37%140.42M |
| Earning before tax | 12.14%7.05B | 18.17%9.88B | -4.53%6.28B | -0.56%8.36B | 27.39%6.58B | 18.84%8.41B | 15.07%5.17B | 6.57%7.08B | -22.70%4.49B | -28.16%6.64B |
| Tax | -20.05%-1.51B | -23.61%-2.11B | 11.23%-1.25B | 3.29%-1.7B | -31.85%-1.41B | -0.52%-1.76B | -27.28%-1.07B | -13.63%-1.75B | 25.16%-841.83M | 4.25%-1.54B |
| After-tax profit from continuing operations | 10.17%5.54B | 16.78%7.78B | -2.69%5.03B | 0.16%6.66B | 26.23%5.17B | 24.87%6.65B | 12.25%4.09B | 4.43%5.32B | -22.11%3.65B | -33.21%5.1B |
| Earning after tax | 10.17%5.54B | 16.78%7.78B | -2.69%5.03B | 0.16%6.66B | 26.23%5.17B | 24.87%6.65B | 12.25%4.09B | 4.43%5.32B | -22.11%3.65B | -33.21%5.1B |
| Minority profit | 25.06%2.94B | 24.17%3.92B | 9.53%2.35B | 9.70%3.16B | 29.40%2.14B | 42.04%2.88B | 54.71%1.66B | 11.88%2.03B | -35.03%1.07B | -49.61%1.81B |
| Profit attributable to shareholders | -2.87%2.6B | 10.11%3.85B | -11.35%2.68B | -7.13%3.5B | 24.07%3.03B | 14.31%3.77B | -5.40%2.44B | 0.33%3.3B | -15.09%2.58B | -18.61%3.29B |
| Basic earnings per share | -4.65%0.41 | 8.93%0.61 | -10.42%0.43 | -6.67%0.56 | 23.08%0.48 | 15.38%0.6 | -4.88%0.39 | 0.00%0.52 | -14.58%0.41 | -18.75%0.52 |
| Diluted earnings per share | -4.65%0.41 | 8.93%0.61 | -10.42%0.43 | -6.67%0.56 | 23.08%0.48 | 15.38%0.6 | -4.88%0.39 | 0.00%0.52 | -14.58%0.41 | -18.75%0.52 |
| Currency Unit | CNY | CNY | CNY | CNY | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.